Radiodermatitis Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Apr 2018| TMR438A| Transparency

Report Highlights

Global Radiodermatitis Market: Overview

Radiodermatitis, also known as radiation dermatitis, is a peculiar symptom caused as a result of radiation therapy pertaining to the treatment of cancerous as well as noncancerous conditions, and has significant negative impact on a patient’s physical functionalities and quality of life. It has been estimated that in developed countries such as the U.S., Canada, Australia, the U.K, France, and Germany, nearly half of the patients who receive treatment for cancer was also subjected to radiation therapy during the illness, and about all of them experience some degree of skin reaction. As the cases of cancer escalates across the world, the demand in the global radiodermatitis is expected to increment at a considerable CAGR of 3.93% during the forecast period of 2017 to 2024.

This report, developed by a group of professional market research analysts, aspires to serve as a credible business tool for the stakeholders of this market. The report studies the prospects of various segments of the market, based on product, distribution channel, and geography, as well as profiles a number of leading players to understand the competitive landscape. Qualitative and quantitative assessment of all factors that may influence the demand for radiodermatitis has been provided in the report.

Global Radiodermatitis Market: Trends & Opportunities

According to the International Agency for Research on Cancer (IARC), there were 14.1 million new cases of cancer across the world, and the figure is estimated to reach up to 21.7 million by the end of 2030. This substantial patient volume is the primary driver of the global radiodermatitis market. In addition to that, increasing focus on product innovation as well as advancements in the existing products are also expected to favor the market in the near future. Growing number of private and public healthcare organizations, who are constantly trying to promote the awareness regarding radiodermatitis treatment and management, and rising number of clinical studies to evaluate the efficiency of radiodermatitis treatment are some of the other factors favoring the global radiodermatitis market.

Based on product, the global radiodermatitis market has been segmented into topical, oral medication, and dressings. While topical segment is sub-segmented into hydrophilic creams, corticosteroids, and others such as antibiotics, oral medical is further divided into corticosteroids and others such as antibiotics and oral analgesics, whereas dressing segment is further categorized into hydrogel, no sting barrier film, hydrocolloid, honey impregnated gauze, silicone coated dressing, and others such as silver leaf dressing and GM-CSF gauze. On the basis of dressing channel, the market has been bifurcated into hospital pharmacy, online store, and retail pharmacy store.

Global Radiodermatitis Market: Regional Outlook

Though the demand for radiodermatitis is growing in all regions across the globe, Asia Pacific currently serves the maximum demand, owing to higher percentage untapped patient-base. A number of emerging economies in the Asian region are situated in tropical region with humid weather conditions, in which the effect of radiation dermatitis is quite high. Extensive collaborations among the key players in order to increase their product portfolio and involvement of well-established pharmaceutical companies in this region on commercialization of their products are also expected to help them increment their shares in this region.

Companies mentioned in the research report

Smith & Nephew plc, 3M Healthcare, Acelity, Convatec, Inc., and Molnlycke Health Care are some of the key companies operating in this market.

Key Segments of the Global Radiodermatitis Market

Global Radiodermatitis Market, by Product
Topical
Corticosteroids
Hydrophilic Creams
Others (topical antibiotics)
Oral Medication
Corticosteroids
Other (oral analgesics, antibiotics, etc.)
Dressings
Hydrogel
Hydrocolloid
No Sting Barrier Film
Honey Impregnated Gauze
Silicone Coated Dressing
Others (GM-CSF gauze, silver leaf dressing, etc.)

Global Radiodermatitis Market, by Distribution Channel
Hospital Pharmacy
Retail Pharmacy Store
Online Store

Global Radiodermatitis Market, by Geography
North America
U.S.
Canada
Asia Pacific
China
Japan

Rest of APAC
Europe
U.K.
Germany

Rest of Europe
Latin America
Brazil
Mexico

Rest of Latin America
Middle East & Africa
UAE
South Africa

Rest of Middle East & Africa

This report gives you access to decisive data such as:

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming years
Key highlights of this report

Overview of key market forces propelling and restraining market growth
Up-to-date analyses of market trends and technological improvements
Pin-point analyses of market competition dynamics to offer you a competitive edge
An analysis of strategies of major competitors
An array of graphics and SWOT analysis of major industry segments
Detailed analyses of industry trends
A well-defined technological growth map with an impact-analysis
Offers a clear understanding of the competitive landscape and key product segments

  • Table 1 : Global Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
  • Table 2 : Global Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
  • Table 3 : List of Discontinued Clinical Trials
  • Table 4 : List of Open Clinical Trials
  • Table 5 : Global Radiodermatitis Market Size (US$ Mn) Forecast, by Region, 2016–2024
  • Table 6 : North America Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
  • Table 7 : North America Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
  • Table 8 : North America Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
  • Table 9 : Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
  • Table 10 : Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
  • Table 11 : Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 12 : Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
  • Table 13 : Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
  • Table 14 : Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 15 : Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
  • Table 16 : Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
  • Table 17 : Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
  • Table 18 : Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
  • Table 19 : Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
  • Table 20 : Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
  • Figure 1 : Global Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
  • Figure 2 : Global Radiodermatitis Market Value Share Analysis, by Product Type, 2015 and 2024
  • Figure 3 : Global Topical Products Market Revenue (US$ Mn), 2014–2024
  • Figure 4 : Global Oral Medication Market Revenue (US$ Mn), 2014–2024
  • Figure 5 : Global Dressings Market Revenue (US$ Mn), 2014–2024
  • Figure 6 : Global Topical Corticosteroids Market Revenue (US$ Mn), 2014–2024
  • Figure 7 : Global Hydrophilic Creams Market Revenue (US$ Mn), 2014–2024
  • Figure 8 : Global Other Topical agents Market Revenue (US$ Mn), 2014–2024
  • Figure 9 : Global Oral Analgesic, Anti-inflammatory & Antibiotic Market Revenue (US$ Mn), 2014-2024
  • Figure 10 : Global Oral Corticosteroids Market Revenue (US$ Mn), 2014–2024
  • Figure 11 : Global Hydrogel Market Revenue (US$ Mn), 2014–2024
  • Figure 12 : Global Hydrocolloid Market Revenue (US$ Mn), 2014–2024
  • Figure 13 : Global No Sting Barrier Film Market Revenue (US$ Mn), 2014–2024
  • Figure 14 : Global Honey Impregnated Gauze Market Revenue (US$ Mn), 2014–2024
  • Figure 15 : Global Silicone Coated Dressing Market Revenue (US$ Mn), 2014–2024
  • Figure 16 : Global Other Dressings Market Revenue (US$ Mn), 2014–2024
  • Figure 17 : Radiodermatitis Market Attractiveness Analysis, by Product Type
  • Figure 18 : Global Radiodermatitis Market Value Share Analysis, by Distribution Channel, 2015 and 2024
  • Figure 19 : Global Hospital Pharmacy Market Revenue (US$ Mn), 2014–2024
  • Figure 20 : Global Retail Pharmacy Store Market Revenue (US$ Mn), 2014–2024
  • Figure 21 : Global Online Store Market Revenue (US$ Mn), 2014–2024
  • Figure 22 : Radiodermatitis Market Attractiveness Analysis, by Distribution Channel, 2015
  • Figure 23 : Global Radiodermatitis Market Value Share Analysis, by Region, 2015 and 2024
  • Figure 24 : Radiodermatitis Market Attractiveness Analysis, by Region, 2015
  • Figure 25 : North America Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
  • Figure 26 : North America Market Attractiveness Analysis, by Country, 2015
  • Figure 27 : North America Market Value Share Analysis, by Product Type, 2015 and 2024
  • Figure 28 : North America Market Value Share Analysis, by Distribution Channel, 2015 and 2024
  • Figure 29 : North America Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 30 : North America Market Attractiveness Analysis, by Product Type, 2015
  • Figure 31 : North America Market Attractiveness Analysis, by Distribution Channel, 2015
  • Figure 32 : Europe Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
  • Figure 33 : Europe Market Attractiveness Analysis, by Country, 2015
  • Figure 34 : Europe Market Value Share Analysis, by Product Type, 2015 and 2024
  • Figure 35 : Europe Market Value Share Analysis, by Distribution Channel, 2015 and 2024
  • Figure 36 : Europe Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 37 : Europe Market Attractiveness Analysis, by Product Type, 2015
  • Figure 38 : Europe Market Attractiveness Analysis, by Distribution Channel, 2015
  • Figure 39 : Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
  • Figure 40 : Asia Pacific Market Attractiveness Analysis, by Country, 2015
  • Figure 41 : Asia Pacific Market Value Share Analysis, by Product Type, 2015 and 2024
  • Figure 42 : Asia Pacific Market Value Share Analysis, by Distribution Channel, 2015 and 2024
  • Figure 43 : Asia Pacific Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 44 : Asia Pacific Market Attractiveness Analysis, by Product Type, 2015
  • Figure 45 : Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2015
  • Figure 46 : Latin America Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
  • Figure 47 : Latin America Market Attractiveness Analysis, by Country, 2015
  • Figure 48 : Latin America Market Value Share Analysis, by Product Type, 2015 and 2024
  • Figure 49 : Latin America Market Value Share Analysis, by Distribution Channel, 2015 and 2024
  • Figure 50 : Latin America Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 51 : Latin America Market Attractiveness Analysis, by Product Type, 2015
  • Figure 52 : Latin America Market Attractiveness Analysis, by Distribution Channel, 2015
  • Figure 53 : Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
  • Figure 54 : Middle East & Africa Market Attractiveness Analysis, by Country, 2015
  • Figure 55 : Middle East & Africa Market Value Share Analysis, by Product Type, 2015 and 2024
  • Figure 56 : Middle East & Africa Market Value Share Analysis by Distribution Channel, 2015 and 2024
  • Figure 57 : Middle East & Africa Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 58 : Middle East & Africa Market Attractiveness Analysis, by Product Type, 2015
  • Figure 59 : Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2015
  • Figure 60 : Global Radiodermatitis Market Share Analysis by Company (2015)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report